Status:
COMPLETED
A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B
Lead Sponsor:
Bio Products Laboratory
Conditions:
Haemophilia B
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is: * to compare the pharmacokinetics of Replenine®-VF and Replenine® or any other high purity Factor IX concentrate, when given as a bolus dose of 75IU/kg. * to compare the...
Eligibility Criteria
Inclusion
- Patients aged 12 years or over
- At least 20 exposures suffering from severe Haemophilia B and without inhibitors to Factor IX and on Replenine® or any other high purity Factor IX product
Exclusion
- \-
Key Trial Info
Start Date :
July 1 1997
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02263456
Start Date
July 1 1997
Last Update
October 13 2014
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Free Hospital, Pond Street
Hampstead, London, United Kingdom
2
The North Hampshire Hospital, Aldermaston Road
Basingstoke, United Kingdom
3
Addenbrooke's Hospital, Hills Road
Cambridge, United Kingdom
4
University Hospital of Wales, Health Park
Cardiff, United Kingdom